Tortorella Cinzia, Neri Giuliano, Nussdorfer Gastone G
Department of Human Anatomy and Physiology, Section of Anatomy, University of Padua, I-35121 Padua, Italy.
Int J Mol Med. 2007 Apr;19(4):639-47.
Galanin is a regulatory 30- or 29-amino acid peptide, widely distributed in the nervous system and gut, that acts via three subtypes of G protein-coupled receptors, named GAL-R1, GAL-R2 and GAL-R3. Findings have been accumulated that galanin regulates neuroendocrine hypothalamic axes, including the hypothalamic-pituitary-adrenal (HPA) one. Galanin and its receptors are expressed in the hypothalamic paraventricular and supraoptic nuclei, anterior pituitary and adrenal medulla. Adrenal cortex does not express galanin, but is provided with GAL-R1 and GAL-R2. The bulk of evidence indicates that galanin stimulates the activity of the central branch of the HPA axis (i.e. the release of corticotropin-releasing hormone and ACTH), thereby enhancing glucocorticoid secretion from the adrenal cortex. Investigations carried out in the rat show that galanin is also able to directly stimulate corticosterone (glucocorticoid) secretion from adrenocortical cells, through GAL-R1 and GAL-R2 coupled to the adenylate cyclase-protein kinase A signaling cascade, and nor-epinephrine release from adrenal medulla. There is indication that galanin may also enhance corticosterone release via an indirect paracrine mechanism involving the local release of catecholamines, which in turn activate beta-adrenoceptors located on adrenocortical cells. The physiological relevance in the rat of the glucocorticoid secretagogue action of galanin is suggested by the demonstration that the blockade of galanin system significantly lowers basal corticosterone secretion. There is also evidence that galanin plays a role in the modulation of HPA-axis response to stress, as well as in the pathogenesis of pituitary adenomas and perhaps of pheochromocytomas.
甘丙肽是一种由30个或29个氨基酸组成的调节性肽,广泛分布于神经系统和肠道,通过三种G蛋白偶联受体亚型发挥作用,分别命名为GAL-R1、GAL-R2和GAL-R3。越来越多的研究发现,甘丙肽可调节神经内分泌下丘脑轴,包括下丘脑-垂体-肾上腺(HPA)轴。甘丙肽及其受体在下丘脑室旁核和视上核、垂体前叶和肾上腺髓质中表达。肾上腺皮质不表达甘丙肽,但有GAL-R1和GAL-R2。大量证据表明,甘丙肽可刺激HPA轴中枢支的活性(即促肾上腺皮质激素释放激素和促肾上腺皮质激素的释放),从而增强肾上腺皮质的糖皮质激素分泌。在大鼠身上进行的研究表明,甘丙肽还能够通过与腺苷酸环化酶-蛋白激酶A信号级联相关的GAL-R1和GAL-R2,直接刺激肾上腺皮质细胞分泌皮质酮(糖皮质激素),并刺激肾上腺髓质释放去甲肾上腺素。有迹象表明,甘丙肽还可能通过一种间接旁分泌机制增强皮质酮释放,该机制涉及儿茶酚胺的局部释放,进而激活位于肾上腺皮质细胞上的β-肾上腺素能受体。甘丙肽系统被阻断会显著降低基础皮质酮分泌,这表明了甘丙肽在大鼠体内糖皮质激素促分泌作用的生理相关性。也有证据表明,甘丙肽在调节HPA轴对应激的反应以及垂体腺瘤甚至嗜铬细胞瘤的发病机制中发挥作用。